专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4312744A FCC Process using low coke-make FCC catalyst 失效
标题翻译： FCC工艺使用低焦炭FCC催化剂
公开(公告)号：US4312744A
公开(公告)日：1982-01-26
申请号：US232497
申请日：1981-02-09
申请人： Hosheng Tu , David C. DeCoster
发明人： Hosheng Tu , David C. DeCoster
IPC分类号： B01J29/08 , C10G11/05
CPC分类号： B01J29/084 , C10G11/05
摘要： A process for cracking a hydrocarbon charge stock which uses a catalytic composite prepared by mixing a zeolitic crystalline aluminosilicate dispersed in a porous carrier material with a solution of rare earth salt, separating a filter cake from the slurry by a means not involving the washing of the filter cake and calcining the filter cake.
摘要翻译：一种裂解烃电荷原料的方法，该方法使用通过将分散在多孔载体材料中的沸石结晶硅铝酸盐与稀土盐溶液混合制备的催化复合物，通过不涉及洗涤滤饼并煅烧滤饼。

2. 发明授权

US4263174A Low coke-make FCC catalyst 失效
标题翻译：低焦炭FCC催化剂
公开(公告)号：US4263174A
公开(公告)日：1981-04-21
申请号：US70935
申请日：1979-08-29
申请人： Hosheng Tu , David C. DeCoster
发明人： Hosheng Tu , David C. DeCoster
IPC分类号： B01J29/08 , C10G11/05
CPC分类号： C10G11/05 , B01J29/084
摘要： A catalytic composite, its method of manufacture and use is disclosed. The composite comprises a zeolitic crystalline aluminosilicate dispersed in a porous inorganic oxide carrier material comprising silica, alumina or zirconium and a constituent comprising the ions of one or more rare earths with the weight ratio on a volatile free basis of the rare earth ions to the carrier material being greater than 1.0:100.0. The method of manufacture of the composite comprises mixing a catalyst powder comprising the zeolite dispersed in a porous inorganic oxide carrier material with a solution of a salt of the rare earth, separating a filter cake from the slurry by a means not involving the washing of the filter cake and calcining the filter cake. The catalytic composite may be used in a process for cracking a hydrocarbon charge stock.
摘要翻译：公开了一种催化复合材料及其制造和使用方法。复合材料包括分散在包含二氧化硅，氧化铝或锆的多孔无机氧化物载体材料中的沸石结晶硅铝酸盐和包含一种或多种稀土离子的成分，其中稀土离子的挥发性游离基与载体的重量比材料大于1.0：100.0。制造复合材料的方法包括将分散在多孔无机氧化物载体材料中的沸石的催化剂粉末与稀土盐的溶液混合，通过不涉及洗涤滤饼并煅烧滤饼。催化复合材料可用于裂解烃原料的方法。

3. 发明授权

US4299688A FCC Process using low coke-make FCC catalyst 失效
标题翻译： FCC工艺使用低焦炭FCC催化剂
公开(公告)号：US4299688A
公开(公告)日：1981-11-10
申请号：US200163
申请日：1980-10-24
申请人： Hosheng Tu , David C. DeCoster
发明人： Hosheng Tu , David C. DeCoster
IPC分类号： B01J29/08 , C10G11/05
CPC分类号： C10G11/05 , B01J29/084
摘要： This invention comprises a process for cracking a hydrocarbon charge stock using a zeolitic crystalline aluminosilicate dispersed in a porous inorganic oxide carrier material comprising silica, alumina or zirconium and a constituent comprising the ions of one or more rare earths with the weight ratio on a volatile free basis of the rare earth ions to the carrier material being greater than 1.0:100.0. The method of manufacture of the composite comprises mixing a catalyst powder comprising the zeolite dispersed in a porous inorganic oxide carrier material with a solution of a salt of the rare earth, separating a filter cake from the slurry by a means not involving the washing of the filter cake and calcining the filter cake.
摘要翻译：本发明包括使用分散在包含二氧化硅，氧化铝或锆的多孔无机氧化物载体材料中的沸石结晶硅铝酸盐以及包含一种或多种稀土离子的组分，其重量比为挥发性无机物的裂化烃电荷原料的方法载体材料的稀土离子的基础大于1.0：100.0。制造复合材料的方法包括将分散在多孔无机氧化物载体材料中的沸石的催化剂粉末与稀土盐的溶液混合，通过不涉及洗涤滤饼并煅烧滤饼。

4. 发明授权

US08579846B2 Ocular implant systems 有权
标题翻译：眼植入系统
公开(公告)号：US08579846B2
公开(公告)日：2013-11-12
申请号：US13301648
申请日：2011-11-21
申请人： Hosheng Tu , Gregory T. Smedley , David Haffner , Barbara A. Niksch
发明人： Hosheng Tu , Gregory T. Smedley , David Haffner , Barbara A. Niksch
IPC分类号： A61B19/00 , A61F11/00
CPC分类号： A61M27/00 , A61F9/00781
摘要： Implants and methods for treating ocular disorders are disclosed. One implant has a tubular member, with inlet and outlet ends, and a cutting member connected thereto. The tubular member is configured to extend through eye tissue such that the inlet and outlet ends reside respectively in an anterior chamber and a physiologic outflow pathway of the eye. Desirably, the cutting member is configured to make an incision in the eye tissue for receiving at least a portion of the tubular member. One method involves introducing an implant, with proximal and distal ends, into the anterior chamber and penetrating eye tissue using an implant distal portion. The implant is advanced from the anterior chamber into the penetrated eye tissue to locate the distal and proximal ends respectively in the physiologic outflow pathway and the anterior chamber. Aqueous humor is conducted between the proximal and distal ends.
摘要翻译：公开了用于治疗眼部疾病的植入物和方法。一个植入物具有管状构件，其具有入口端和出口端以及与其连接的切割构件。管状构件构造成延伸穿过眼睛组织，使得入口端和出口端分别位于眼睛的前房和生理流出路径中。期望地，切割构件被配置为在眼组织中进行切口以接收管状构件的至少一部分。一种方法包括使用植入物远端部分将具有近端和远端的植入物引入前房和穿透眼组织。植入物从前房进入穿透的眼组织，将远端和近端分别定位在生理流出道和前房中。在近端和远端之间进行水性幽默。

5. 发明授权

US08318198B1 Pharmaceutical composition of nanoparticles 失效
公开(公告)号：US08318198B1
公开(公告)日：2012-11-27
申请号：US13527886
申请日：2012-06-20
申请人： Hsing-Wen Sung , Zi-Xian Liao , Min-Fan Chung , Ko-Jie Chen , Hosheng Tu
发明人： Hsing-Wen Sung , Zi-Xian Liao , Min-Fan Chung , Ko-Jie Chen , Hosheng Tu
IPC分类号： A61L15/00
CPC分类号： A61K9/0004 , A61K9/1272 , A61K9/1278 , A61K9/5146 , A61K9/5153 , A61K9/5161 , A61K31/337 , A61K31/4745 , A61K31/704
摘要： The invention discloses a pharmaceutical composition of liposome nanoparticles for lodging in a target tissue cell in situ of an animal subject, the nanoparticles comprising at least one thermal triggered phase-transition compound as a targeting drug delivery system for physical cancer therapy.

6. 发明授权

US08287594B2 Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis 有权
标题翻译：膝关节假体和用于治疗骨关节炎的透明质酸盐组合物
公开(公告)号：US08287594B2
公开(公告)日：2012-10-16
申请号：US12949204
申请日：2010-11-18
申请人： Andrew H. Cragg , Richard J. Greff , George Wallace , Robert J. Socci, Jr. , Jonathan Kagan , Rodolfo C. Quijano , Hosheng Tu
发明人： Andrew H. Cragg , Richard J. Greff , George Wallace , Robert J. Socci, Jr. , Jonathan Kagan , Rodolfo C. Quijano , Hosheng Tu
IPC分类号： A61F2/08
CPC分类号： A61F2/30756 , A61F2/3872 , A61F2/461 , A61F2002/4635 , A61L27/20 , A61L27/50 , A61L27/52 , C08L5/08
摘要： A medical device and methods to relieve joint pain and adapted for knee joint repair, replacement and augmentation. The invention discloses joint lubricant, particularly hyaluronate compositions and methods for treatment of osteoarthritis.
摘要翻译：一种减轻关节疼痛并适应膝关节修复，置换和增大的医疗装置和方法。本发明公开了关节润滑剂，特别是透明质酸盐组合物和治疗骨关节炎的方法。

7. 发明授权

US08236281B1 Pharmaceutical composition of nanoparticles 有权
标题翻译：纳米粒子的药物组成
公开(公告)号：US08236281B1
公开(公告)日：2012-08-07
申请号：US13449157
申请日：2012-04-17
申请人： Hsing-Wen Sung , Kiran Sonaje , Hosheng Tu
发明人： Hsing-Wen Sung , Kiran Sonaje , Hosheng Tu
IPC分类号： A61K51/00
CPC分类号： A61K31/13 , A61K9/0043 , A61K9/5146 , A61K9/5161 , A61K31/445 , A61K31/55
摘要： The invention relates to a pharmaceutical composition of nanoparticles, wherein the nanoparticles comprise positively charged chitosan, a negatively charged substrate, optionally a zero-charge compound, and at least one bioactive agent for treating diabetes of an animal subject.
摘要翻译：本发明涉及纳米颗粒的药物组合物，其中纳米颗粒包含带正电荷的壳聚糖，带负电荷的底物，任选的零电荷化合物和用于治疗动物受试者的糖尿病的至少一种生物活性剂。

8. 发明授权

US08226602B2 Intragastric balloon system and therapeutic processes and products 有权
标题翻译：内窥镜气囊系统及治疗过程及产品
公开(公告)号：US08226602B2
公开(公告)日：2012-07-24
申请号：US11694536
申请日：2007-03-30
申请人： Rodolfo C. Quijana , Andrew H. Cragg , Hosheng Tu , Stephen A. Sosnowski , George Wallace
发明人： Rodolfo C. Quijana , Andrew H. Cragg , Hosheng Tu , Stephen A. Sosnowski , George Wallace
IPC分类号： A61M31/00 , A61M37/00
CPC分类号： A61F5/0003 , A61F5/0036 , A61F5/0046
摘要： A gastric space filler device for treating obesity in a patient by reducing the stomach volume features at least one inflatable space filler with drag delivery and stimulation features and includes therapeutic devices and anchoring apparatus enabling tracking, visualization and optimized management of inter-balloon connecting sections, drug reservoirs and pumping systems along with related improvements.
摘要翻译：一种用于通过减少胃体积特征的用于治疗患者肥胖的胃空间填充装置，具有药物递送和刺激特征的至少一个可充气空间填充物，并且包括能够跟踪，可视化和优化管理球囊间连接部分的治疗装置和锚定装置，药物储库和抽水系统以及相关改进。

9. 发明授权

US08187570B1 Nanoparticles for protein drug delivery 有权
公开(公告)号：US08187570B1
公开(公告)日：2012-05-29
申请号：US13356583
申请日：2012-01-23
申请人： Hsing-Wen Sung , Zi-Xian Liao , Shu-Fen Peng , Hosheng Tu
发明人： Hsing-Wen Sung , Zi-Xian Liao , Shu-Fen Peng , Hosheng Tu
IPC分类号： A61K51/00
CPC分类号： A61K31/13 , A61K9/0043 , A61K9/5146 , A61K9/5161 , A61K31/445 , A61K31/55
摘要： The invention discloses particulate complexes composed of chitosan, poly-glutamic acid, and at least one bioactive agent, wherein equal moles of the positively charged chitosan and the negatively charged poly-glutamic acid substrate form an electrostatic network enabling improved loading the bioactive agent.

10. 发明授权

US08173106B1 Pharmaceutical composition of peptide drug and enzyme-inhibition compounds 有权
标题翻译：肽药物和酶抑制化合物的药物组合物
公开(公告)号：US08173106B1
公开(公告)日：2012-05-08
申请号：US13374135
申请日：2011-12-13
申请人： Hsing-Wen Sung , Kiran Sonaje , Hosheng Tu
发明人： Hsing-Wen Sung , Kiran Sonaje , Hosheng Tu
IPC分类号： A61B5/055
CPC分类号： A61K31/13 , A61K9/0043 , A61K9/5146 , A61K9/5161 , A61K31/445 , A61K31/55 , A61K47/645
摘要： The invention relates to a method of co-administering a peptide or protein drug with an enzyme-resistant PGA-complexone compound orally so to mitigate enzyme attack in the gastrointestinal tract of an animal subject.
摘要翻译：本发明涉及一种通过口服将肽或蛋白质药物与耐酶PGA-配合物化合物共同施用以减轻动物受试者的胃肠道中的酶侵袭的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式